Jagsonpal Pharmaceuticals Limited — Important, 13-03-2025: Updates

The Nomination and Remuneration Committee of Jagsonpal Pharmaceuticals Limited has confirmed the allotment of 11,575 equity shares under the Employee Stock Option Plan, 2022. This issuance has raised the company's paid-up share capital from ₹13,27,74,110 (comprising 6,63,87,055 equity shares) to ₹13,27,97,260 (comprising 6,63,98,630 equity shares). These new shares, associated with an exercise price of ₹94 for 2,200 shares and ₹113.6 for 9,375 shares, are part of the company's strategy to incentivize and reward employees. This move can enhance employee engagement and potentially improve performance, making it a notable development for the company's workforce dynamics.